Signal change in the dentate nucleus on T1-weighted MR images after multiple administrations of gadopentetate dimeglumine versus gadobutrol

American Journal of Roentgenology

Volumn 206, Issue 2, 2016, Pages 414-419

  Cao, Yan ^a   Huang, Daisy Q ^a   Shih, George ^a   Prince, Martin R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Contrast agents; Dentate nucleus; Gadobutrol; Gadolinium; Gadopentetate dimeglumine; Globus pallidus; MRI; Safety

Indexed keywords

GADOBUTROL; GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM; GADOLINIUM PENTETATE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; BRAIN INFECTION; BRAIN METASTASIS; BRAIN TUMOR; BRAIN VASCULITIS; CEREBELLAR PEDUNCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DENTATE NUCLEUS; DRUG EXPOSURE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VERY ELDERLY; BRAIN DISEASES; CEREBELLUM NUCLEUS; COMPARATIVE STUDY; DRUG EFFECTS; MIDDLE AGED; PATHOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BRAIN DISEASES; CEREBELLAR NUCLEI; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84956738724     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.15.15327     Document Type: Article

References (17)

1. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014; 270:834-841
2. Errante Y, Cirimele V, Mallio CA, Di Lazzaro V, Zobel BB, Quattrocchi CC. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol 2014; 49:685-690
3. Adin ME, Kleinberg L, Vaidya D, Zan E, Mirbagheri S, Yousem DM. Hyperintense dentate nuclei on T1-weighted MRI: relation to repeat gadolinium administration. AJNR 2015; 36:1859-1865
4. Weberling LD, Kieslich PJ, Kickingereder P, et al. Increased signal intensity in the dentate nucleus on unenhanced T1-weighted images after gadobenate dimeglumine administration. Invest Radiol 2015; 50:743-748
5. Quattrocchi CC, Mallio CA, Errante Y, et al. Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Invest Radiol 2015; 50:470-472
6. Kanda T, Osawa M, Oba H, et al. High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 2015; 275:803-809
7. Radbruch A, Weberling LD, Kieslich PJ, et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 2015; 275:783-791
8. Stojanov DA, Aracki-Trenkic A, Vojinovic S, Benedeto-Stojanov D, Ljubisavljevic S. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol. Eur Radiol 2015 June 25 [Epub ahead of print]
9. Kanda T, Fukusato T, Matsuda M, et al. Gadoliniumbased contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 2015; 276:228-232
10. McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015; 275:772-782
11. Robert P, Lehericy S, Grand S, et al. T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of gadolinium-based contrast agents in healthy rats: difference between linear and macrocyclic agents. Invest Radiol 2015; 50:473-480
12. Schmitt-Willich H. Stability of linear and macrocyclic gadolinium based contrast agents. Br J Radiol 2007; 80:581-582; author reply, 584-585
13. Tweedle MF. ?Stability? of gadolinium chelates. Br J Radiol 2007; 80:583-584; author reply, 584-585
14. Idée JM, Port M, Raynal I, Schaefer M, Le Greneur S, Corot C. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 2006; 20:563-576
15. Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol 2008; 43:817-828
16. Zucca FA, Basso E, Cupaioli FA, et al. Neuromelanin of the human substantia nigra: an update. Neurotox Res 2014; 25:13-23
17. Zecca L, Zucca FA, Albertini A, Rizzio E, Fariello RG. A proposed dual role of neuromelanin in the pathogenesis of Parkinson?s disease. Neurology 2006; 67:S8-S11